Abstract In the first case regarding the pharmaceutical patent linkage regime in China, the Supreme People’s Court of China ruled that the validity of a patent did not affect a pharmaceutical patent linkage case. Whether the technical solution of the generic drug falls within the scope of protection of a patent should be judged based on the submitted application for marketing authorization, instead of the actual technical solution implemented.
{"title":"The Supreme People’s Court of China ruled on the first pharmaceutical patent linkage case after the new Patent Law","authors":"Hongxuyang Lu","doi":"10.1093/jiplp/jpad004","DOIUrl":"https://doi.org/10.1093/jiplp/jpad004","url":null,"abstract":"Abstract In the first case regarding the pharmaceutical patent linkage regime in China, the Supreme People’s Court of China ruled that the validity of a patent did not affect a pharmaceutical patent linkage case. Whether the technical solution of the generic drug falls within the scope of protection of a patent should be judged based on the submitted application for marketing authorization, instead of the actual technical solution implemented.","PeriodicalId":44529,"journal":{"name":"Journal of Intellectual Property Law & Practice","volume":"13 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135491271","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
... In a world that seems to grow increasingly litigious and complex, one can hardly deny the benefits of amicable settlements. At the very least, such settlements lessen the burden on infringement and validity courts. However, any kind of agreement relating to the validity and/or enforceability of a patent goes to the heart of the relationship between IP and competition law. In the European Union those agreements have to be reviewed carefully under Article 101 of the Treaty on the Functioning of the European Union (TFEU), to evaluate whether they are compatible with the internal market and do not in any way encumber research and development (R&D), by overextending the temporarily limited monopoly granted by a patent in exchange for the disclosure of an invention. Accordingly, any agreement limiting or prohibiting a party from challenging a patent or providing for a de facto extension of the 20-year monopoly right granted by a patent entails by nature a potential conflict with antitrust. Since patent and antitrust law coexist and both serve legitimate interests, the tension between them is intentional and finding the right balance serves the purpose of driving technological development and fostering technological progress.
{"title":"No-challenge and pay-for-delay agreements in patent licence and settlement agreements under European competition law","authors":"Marco Stief","doi":"10.1093/jiplp/jpad005","DOIUrl":"https://doi.org/10.1093/jiplp/jpad005","url":null,"abstract":"... In a world that seems to grow increasingly litigious and complex, one can hardly deny the benefits of amicable settlements. At the very least, such settlements lessen the burden on infringement and validity courts. However, any kind of agreement relating to the validity and/or enforceability of a patent goes to the heart of the relationship between IP and competition law. In the European Union those agreements have to be reviewed carefully under Article 101 of the Treaty on the Functioning of the European Union (TFEU), to evaluate whether they are compatible with the internal market and do not in any way encumber research and development (R&D), by overextending the temporarily limited monopoly granted by a patent in exchange for the disclosure of an invention. Accordingly, any agreement limiting or prohibiting a party from challenging a patent or providing for a de facto extension of the 20-year monopoly right granted by a patent entails by nature a potential conflict with antitrust. Since patent and antitrust law coexist and both serve legitimate interests, the tension between them is intentional and finding the right balance serves the purpose of driving technological development and fostering technological progress.","PeriodicalId":44529,"journal":{"name":"Journal of Intellectual Property Law & Practice","volume":"76 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135440957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Back to the future: from Brexit to IP 4.0—reshaping Paris, Berne and TRIPS for the 21st century","authors":"A. Tsoutsanis","doi":"10.1093/jiplp/jpab120","DOIUrl":"https://doi.org/10.1093/jiplp/jpab120","url":null,"abstract":"","PeriodicalId":44529,"journal":{"name":"Journal of Intellectual Property Law & Practice","volume":" ","pages":""},"PeriodicalIF":0.5,"publicationDate":"2021-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49008028","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"What patent practitioners can learn from Nalpropion Pharmaceuticals, Inc. v. Actavis Laboratories FL, Inc.","authors":"L. Genieser","doi":"10.1093/jiplp/jpab068","DOIUrl":"https://doi.org/10.1093/jiplp/jpab068","url":null,"abstract":"","PeriodicalId":44529,"journal":{"name":"Journal of Intellectual Property Law & Practice","volume":" ","pages":""},"PeriodicalIF":0.5,"publicationDate":"2021-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45634253","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Seeing Red: representing a mark consisting of a colour combination","authors":"Stefan Martin, Jonathan Boyd","doi":"10.1093/jiplp/jpab110","DOIUrl":"https://doi.org/10.1093/jiplp/jpab110","url":null,"abstract":"","PeriodicalId":44529,"journal":{"name":"Journal of Intellectual Property Law & Practice","volume":" ","pages":""},"PeriodicalIF":0.5,"publicationDate":"2021-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48605965","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Plant Breeders’ Rights v Farmers’ Rights: a contradistinction between the Indian approach and international protection","authors":"Anushka","doi":"10.1093/jiplp/jpaa186","DOIUrl":"https://doi.org/10.1093/jiplp/jpaa186","url":null,"abstract":"","PeriodicalId":44529,"journal":{"name":"Journal of Intellectual Property Law & Practice","volume":" ","pages":""},"PeriodicalIF":0.5,"publicationDate":"2021-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43636560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The scope of legal protection for designs of integrated circuits in Bahraini and comparative legislation","authors":"N. K. Alshawawreh","doi":"10.1093/jiplp/jpab072","DOIUrl":"https://doi.org/10.1093/jiplp/jpab072","url":null,"abstract":"","PeriodicalId":44529,"journal":{"name":"Journal of Intellectual Property Law & Practice","volume":" ","pages":""},"PeriodicalIF":0.5,"publicationDate":"2021-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45987193","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"How pharmaceutical companies can prevent falsified medicine and vaccines from entering African markets","authors":"Marius Schneider, Nora Ho Tu Nam","doi":"10.1093/jiplp/jpab112","DOIUrl":"https://doi.org/10.1093/jiplp/jpab112","url":null,"abstract":"","PeriodicalId":44529,"journal":{"name":"Journal of Intellectual Property Law & Practice","volume":" ","pages":""},"PeriodicalIF":0.5,"publicationDate":"2021-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48348733","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
G 1/19 (Simulations), Enlarged Board of Appeal of the European Patent Office, 10 March 2021 The Enlarged Board of Appeal of the European Patent Office (EPO) held that a computer-implemented simulation of a technical system or process which is claimed as such can, for the purpose of assessing inventive step, solve a technical problem by producing a technical effect going beyond the simulation’s implementation on a computer; and that the established case law on computer-implemented inventions (COMVIK approach) applies to computer-implemented simulations even if these do not have an output having a direct link with physical reality.
G 1/19（模拟），欧洲专利局扩大上诉委员会，2021年3月10日欧洲专利局（EPO）扩大上诉委员会认为，为了评估创造性，通过产生超出模拟在计算机上实现的技术效果来解决技术问题；以及关于计算机实现的发明的既定判例法（COMVIK方法）适用于计算机实现的模拟，即使这些模拟没有与物理现实直接联系的输出。
{"title":"The Patentability of Computer-Implemented Simulations and Implications for Computer-Implemented Inventions (CIIs)","authors":"T. Minssen, M. Aboy","doi":"10.1093/jiplp/jpab098","DOIUrl":"https://doi.org/10.1093/jiplp/jpab098","url":null,"abstract":"\u0000 G 1/19 (Simulations), Enlarged Board of Appeal of the European Patent Office, 10 March 2021\u0000 The Enlarged Board of Appeal of the European Patent Office (EPO) held that a computer-implemented simulation of a technical system or process which is claimed as such can, for the purpose of assessing inventive step, solve a technical problem by producing a technical effect going beyond the simulation’s implementation on a computer; and that the established case law on computer-implemented inventions (COMVIK approach) applies to computer-implemented simulations even if these do not have an output having a direct link with physical reality.","PeriodicalId":44529,"journal":{"name":"Journal of Intellectual Property Law & Practice","volume":" ","pages":""},"PeriodicalIF":0.5,"publicationDate":"2021-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44244568","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Alko Oy v Aldar Latvia SIA, MAO:48/21, 9 February 2021 The Market Court of Finland recently determined trade mark damages in the light of complex circumstances.
{"title":"Market Court of Finland rules on reasonable compensation in a trade mark infringement case concerning cheaper foreign alcohol and a national retailing monopoly","authors":"Max Malvikko, Teemu Matikainen","doi":"10.1093/JIPLP/JPAB111","DOIUrl":"https://doi.org/10.1093/JIPLP/JPAB111","url":null,"abstract":"\u0000 Alko Oy v Aldar Latvia SIA, MAO:48/21, 9 February 2021\u0000 The Market Court of Finland recently determined trade mark damages in the light of complex circumstances.","PeriodicalId":44529,"journal":{"name":"Journal of Intellectual Property Law & Practice","volume":" ","pages":""},"PeriodicalIF":0.5,"publicationDate":"2021-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43022444","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：